Bradmer announces additions to Scientific Advisory Board.
The News Review:
- Bradmer announces additions to Scientific Advisory Board.
- Asia Cryo Cell plans IP
- Michael J. Fox Foundation Launches Rapid Response Innovation Awards…
- Ranbaxy to share Fortis brand name with Dutch co
Bradmer announces additions to Scientific Advisory Board.
Free with registration – PR Newswire – AccessMyLibrary.com – Dec 12, 2007
Black is one of the leading neuro-oncology surgeons in North America having performed more than 5000 operations for the resection of brain tumors the preliminary step in the standard of care of primary glioblastoma multiforme Bradmer’s lead indication. Stupp’s leadership role in European and international cancer research is exemplified by his appointment as the Chairman of the Clinical Research Division of the European rganisation for Research and Treatment of Cancer (ERTC) and his role as lead investigator for numerous international trials in. CPYRIGHT 2007 PR Newswire Association LLC.
Asia Cryo Cell plans IP
Times of India – Dec 12, 2007
According to SAbhaya Kumar vice chairman Asia Cryo Cell which runs cord blood banks underthe brand name LifeCell the company has drawn up ambitious growth plans whichinclude umbilical cordlining and menstrual blood collection increasing thenumber of clinical research and trial centres from one to four including anoverseas unit in Malaysia besides public cord bloodbanking. Kumar said thatprivate cord blood banking units would be increased to 60 from the present 22 bythe end of 2009. “We are targeting Tier III towns as well and we will become apan Indian player in the true sense of the word” hesaid. Codenamed ‘IntegratedLifeCell’ the company will become India’s only fully structured stem cellentity when its public cord blood banking unit goes on stream by July 2008. “Weare now 85% complete in achieving that of being a fully integrated player.
Michael J. Fox Foundation Launches Rapid Response Innovation Awards…
earthtimes.org – Dec 12, 2007
Fox Foundation today announced that it will commit $2 million to a second round of funding in 2008. RRIA is designed to ensure that researchers can pursue good ideas without delay. Under this program the Foundation accepts proposals on a rolling basis with no deadline makes funding decisions within six weeks of application and speeds up to $75000 to one-year basic preclinical or clinical research projects in any Parkinson’s-relevant arena. "RRIA funds ‘flashes of insight’ in real time hopefully helping to open new avenues for PD therapy development" said Katie Hood interim CE of The Michael J. To accommodate these "flashes of insight" the program’s criteria and application process are designed with novelty and speed in mind. Todd Sherer PhD vice president of research programs at MJFF said: "We set up RRIA to attract new researchers to Parkinson’s and to provide support for unorthodox ideas — the sort that could significantly impact PD treatment but that may have little or no preliminary data making it hard or impossible to find traditional funding to carry them out.
Ranbaxy to share Fortis brand name with Dutch co
Economic Times – Dec 12, 2007
?Fortis is presentlyin the process of launching bancassurance activities in India in partnershipwith IDBI and Federal Bank? Ms Tackaert said. ?Asia is clearly aregion where Fortis wants to grow anddevelop. ? The Indiangroup better known for running Ranbaxy one of India?s largestpharmaceutical companies has four healthcare companies under its fold; FortisHealthcare Limited Fortis HealthStaff Fortis Clinical Research and FortisHealth World Pvt. Their names would remain unaffected but the group wouldhave to rebrand Fortis Financial ServicesLtd. The European group?sthree-way insurance joint venture was a victim of the uncertainty over theFortis name. ?The Ranbaxy group had objected to the joint-venture?said Jitender Balakrishnan deputy managing director IDBIBank.
Written by admin on December 12th, 2007 with
no comments.
Read more articles on News.